3 completed, 2 unknown, 1 recruiting, 1 terminated. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 3, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Pain, Neuropathic: new trials by email Literature Review of Pain, Neuropathic trials Research Report on Pain, Neuropathic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain Ketamine, (2R,6R)-hydroxynorketamine, Saline - Pain, Neuropathic | Phase 1 / Phase 2 | Recruiting | Rush University Medical Center | 25 | 2024-09-19 | 2026-08-03 |
| Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers AFA-281 - Pain, Neuropathic, Pain, Inflammatory | Phase 1 | Completed | Afasci Inc | 64 | 2023-04-11 | 2025-10-21 |
| Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery Onabotulinum Toxin A, Normal saline - Chronic Pain, Post-thoracotomy Pain Syndrome | Phase 1 / Phase 2 | Unknown | Allan Vestergaard Danielsen, MD | 30 | 2022-09-01 | 2021-11-09 |
| Safety and Tolerability of NTRX-07 in Healthy Volunteers NTRX-07-SDD - Pain, Neuropathic | Phase 1 | Completed | NeuroTherapia, Inc. | 48 | 2019-10-10 | 2023-11-08 |
| Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy Pregabalin, Opioid - Pain, Neuropathic | Phase 1 | Unknown | Seoul National University Hospital | 60 | 2016-11-26 | 2018-08-07 |
| Gabapentin and Donepezil Combination on Experimental Human Pain Models Gabapentin lower dose, Donepezil, Placebo (Dop) - Pain, Neuropathic | Phase 1 | Completed | GlaxoSmithKline | 48 | 2011-10-11 | 2017-06-12 |
| Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects GSK1014802 low dose, Lidocaine, GSK1014802 high dose - Pain, Neuropathic, Neuropathic Pain | Phase 1 | Terminated | Biogen | 16 | 2009-07-31 | 2017-10-26 |
Neuralgia (7) · Pain (3) · Chronic Pain (2) · Hyperalgesia (1) · Pain, Postoperative (1)
Nervous System Diseases (7) · Neurologic Manifestations (7) · Neuromuscular Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Peripheral Nervous System Diseases (7) · Signs and Symptoms (7) · Pain (4) · Pathologic Processes (1) · Postoperative Complications (1) · Sensation Disorders (1) · Somatosensory Disorders (1)
6-hydroxynorketamine (1) · Analgesics, Opioid (1) · Donepezil (1) · Gabapentin (1) · Ketamine (1) · Lidocaine (1) · Pregabalin (1) · Saline Solution (1) · Sodium Chloride (1) · gamma-Aminobutyric Acid (1) · onabotulinum toxin A (1) · vixotrigine (1)
Afasci Inc (1) · Allan Vestergaard Danielsen, MD (1) · Biogen (1) · GlaxoSmithKline (1) · NeuroTherapia, Inc. (1) · Rush University Medical Center (1) · Seoul National University Hospital (1)
United States (3) · Denmark (1) · South Korea (1) · United Kingdom (1)
Allan V Danielsen, MD (1) · Asokumar Buvanendran, MD (1) · Chun Kee Chung, MD, PhD (1) · Joseph Foss, MD (1) · Xinmin Xie, MD, PhD (1)